Renaissance BioScience to receive $500k funding for its next-generation yeasts

Published: 8-Jun-2017

Renaissance is a privately held applied life sciences company that develops yeast-based platform technologies for the global food and beverage, alcohol, animal and human nutrition, biofuel and pharmaceutical industries

Renaissance BioScience Corp., a leading global yeast technology company, is pleased to announce that it will receive a multi-year, non-repayable contribution of up to $500,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

The funding will support the company’s ongoing research and development efforts through the advancement of its proprietary, non-GMO yeast strain development platform.

As part of the company’s ongoing focus to develop innovative non-GMO yeast technology, RBSC is engaged in not only the research and development of novel yeast strains for commercialisation, but also the discovery and utilisation of advanced technology capable of improving the company’s proprietary strain development platform.

“We are pleased to receive funding from IRAP in support of furthering our next-generation non-GMO yeast development platform,” said Dr Matthew Dahabieh, Chief Science Officer.

“The assistance offered by IRAP is an important catalyst for us to enhance our strain development capabilities and will enable us to take the next step in offering innovative next-generation yeast technology to our customers. We thank the Government of Canada and IRAP and for their support.”

You may also like